The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L., & Schwartz, J.-C. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,609
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop
Parent, A., & Hazrati, L.-N. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00007-c · Cited by 2,161 · cited 1×
“The striatum receives glutamate inputs from the cerebral cortex and thalamu”
BackgroundEhringer, H., & Hornykiewicz, O. (1960) · Klinische Wochenschrift · doi:10.1007/bf01485901 · Cited by 1,867
Parkinson, J. (2002) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.14.2.223 · Cited by 1,628
Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
Modification of Parkinsonism — Chronic Treatment with L-Dopa
Cotzias, G. C., Papavasiliou, P. S., & Gellene, R. (1969) · New England Journal of Medicine · doi:10.1056/nejm196902132800701 · Cited by 1,284
3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists
CARLSSON, A., LINDQVIST, M., & MAGNUSSON, T. (1957) · Nature · doi:10.1038/1801200a0 · Cited by 1,278
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
Functional anatomy of the basal ganglia
Yelnik, J. (2002) · Movement Disorders · doi:10.1002/mds.10138 · Cited by 952
Dopamine Receptor Binding Enhancement Accompanies Lesion-Induced Behavioral Supersensitivity
Creese, I., Burt, D. R., & Snyder, S. H. (1977) · Science · doi:10.1126/science.877576 · Cited by 712 · cited 1×
“Indeed, striatal D2 dopamine receptor binding sites are increased in the post-mortem tissue of untreated patients with PD and in animal model”
BackgroundLévesque, D., Diaz, J., Pilon, C., Martres, M. P., Giros, B., Souil, E., Schott, D., Morgat, J. L., Schwartz, J. C., & Sokoloff, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8155 · Cited by 674
"ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY
Marsden, C. D., & Parkes, J. D. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91416-1 · Cited by 661
Cenci, M. A., Lee, C. S., & Björklund, A. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00285.x · Cited by 641
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies.
Levey, A. I., Hersch, S. M., Rye, D. B., Sunahara, R. K., Niznik, H. B., Kitt, C. A., Price, D. L., Maggio, R., Brann, M. R., & Ciliax, B. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.8861 · Cited by 626
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
Pilla, M., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., Schwartz, J.-C., Everitt, B. J., & Sokoloff, P. (1999) · Nature · doi:10.1038/22560 · Cited by 565
Schiffmann, S. N., Jacobs, O., & Vanderhaeghen, J. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08257.x · Cited by 530
Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease
Metman, L. V., Del Dotto, P., van den Munckhof, P., Fang, J., Mouradian, M. M., & Chase, T. N. (1998) · Neurology · doi:10.1212/wnl.50.5.1323 · Cited by 514
Gerfen, C., McGinty, J., & Young, W. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-04-01016.1991 · Cited by 504
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia
Calabresi, P., Pisani, A., Mercuri, N. B., & Bernardi, G. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)81862-5 · Cited by 463
Mitchell, I. J., Clarke, C. E., Boyce, S., Robertson, R. G., Peggs, D., Sambrook, M. A., & Crossman, A. R. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90120-6 · Cited by 460
Receptor basis for dopaminergic supersensitivity in Parkinson's disease
LEE, T., SEEMAN, P., RAJPUT, A., FARLEY, I. J., & HORNYKIEWICZ, O. (1978) · Nature · doi:10.1038/273059a0 · Cited by 446
Speculations on the Functional Anatomy of Basal Ganglia Disorders
Penney, J. B., & Young, A. B. (1983) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.06.030183.000445 · Cited by 417
Aizman, O., Brismar, H., Uhlén, P., Zettergren, E., Levey, A. I., Forssberg, H., Greengard, P., & Aperia, A. (2000) · Nature Neuroscience · doi:10.1038/72929 · Cited by 415
Brooks, D. J., Ibanez, V., Sawle, G. V., Playford, E. D., Quinn, N., Mathias, C. J., Lees, A. J., Marsden, C. D., Bannister, R., & Frackowiak, R. S. J. (1992) · Annals of Neurology · doi:10.1002/ana.410310209 · Cited by 396
A Complex Program of Striatal Gene Expression Induced by Dopaminergic Stimulation
Berke, J. D., Paletzki, R. F., Aronson, G. J., Hyman, S. E., & Gerfen, C. R. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05301.1998 · Cited by 356
Parkinson Study Group (1996) · Annals of Neurology · doi:10.1002/ana.410390107 · Cited by 356
Kanda, T., Jackson, M. J., Smith, L. A., Pearce, R. K. B., Nakamura, J., Kase, H., Kuwana, Y., & Jenner, P. (1998) · Annals of Neurology · doi:10.1002/ana.410430415 · Cited by 354
A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions
Ivar Walaas, S., Aswad, D. W., & Greengard, P. (1983) · Nature · doi:10.1038/301069a0 · Cited by 345
Induction of dopamine D 3 receptor expression as a mechanism of behavioral sensitization to levodopa
Bordet, R., Ridray, S., Carboni, S., Diaz, J., Sokoloff, P., & Schwartz, J.-C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3363 · Cited by 345
Molecular effects of dopamine on striatal-projection pathways
Gerfen, C. R. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00019-7 · Cited by 341
L-Dopa-Induced Release of Cerebral Monoamines
Ng, K. Y., Chase, T. N., Colburn, R. W., & Kopin, I. J. (1970) · Science · doi:10.1126/science.170.3953.76 · Cited by 331
Levodopa‐induced dyskinesias improved by a glutamate antagonist in parkinsonia monkeys
Papa, S. M., & Chase, T. N. (1996) · Annals of Neurology · doi:10.1002/ana.410390505 · Cited by 292
Gerfen, C., Keefe, K., & Gauda, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-08167.1995 · Cited by 283
Crossman, A. R. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90322-8 · Cited by 282
William Langston, J., & Ballard, P. (1984) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100046333 · Cited by 281
Synaptic transmission in the striatum: from plasticity to neurodegeneration
Calabresi, P. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00030-1 · Cited by 280
Dunah, A. W., Wang, Y., Yasuda, R. P., Kameyama, K., Huganir, R. L., Wolfe, B. B., & Standaert, D. G. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23206-5 · Cited by 263
De La Fuente‐Fernández, R., Lu, J., Sossi, V., Jivan, S., Schulzer, M., Holden, J. E., Lee, C. S., Ruth, T. J., Calne, D. B., & Stoessl, A. J. (2001) · Annals of Neurology · doi:10.1002/ana.65 · Cited by 247
Crossman, A. R. (1990) · Movement Disorders · doi:10.1002/mds.870050203 · Cited by 245
Filion, M., Tremblay, L., & Be´dard, P. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90586-k · Cited by 235
Control of on/off phenomenon by continuous intravenous infusion of levodopa
Quinn, N., Parkes, J. D., & Marsden, C. D. (1984) · Neurology · doi:10.1212/wnl.34.9.1131 · Cited by 232
FAHN, S. (1974) · Neurology · doi:10.1212/wnl.24.5.431 · Cited by 230
Colzi, A., Turner, K., & Lees, A. J. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.5.573 · Cited by 225
Rascol, O. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530260044017 · Cited by 224
Pearce, R. K. B., Banerji, T., Jenner, P., & David Marsden, C. (1998) · Movement Disorders · doi:10.1002/mds.870130207 · Cited by 220
Continuous dopamine-receptor stimulation in early Parkinson's disease
Olanow, C. W., Schapira, A. H. V., & Rascol, O. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00030-6 · Cited by 208
Beneficial effects of amantadine onL-dopa-induced dyskinesias in Parkinson's disease
Luginger, E., Wenning, G. K., B�sch, S., & Poewe, W. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<873::aid-mds1017>3.0.co;2-i · Cited by 203
AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys
Konitsiotis, S., Blanchet, P. J., Verhagen, L., Lamers, E., & Chase, T. N. (2000) · Neurology · doi:10.1212/wnl.54.8.1589 · Cited by 201
Dumartin, B., Caillé, I., Gonon, F., & Bloch, B. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01650.1998 · Cited by 195
Engber, T. M., Susel, Z., Kuo, S., Gerfen, C. R., & Chase, T. N. (1991) · Brain Research · doi:10.1016/0006-8993(91)90667-k · Cited by 194
Boraud, T., Bezard, E., Bioulac, B., & Gross, C. E. (2001) · Brain · doi:10.1093/brain/124.3.546 · Cited by 193
Self-citationEffects of apomorphine on globus pallidus neurons in parkinsonian patients
Hutchison, W. D., Levy, R., Dostrovsky, J. O., Lozano, A. M., & Lang, A. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420513 · Cited by 192
Boraud, T., Bezard, E., Guehl, D., Bioulac, B., & Gross, C. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01563-1 · Cited by 190
Self-citationPostsynaptic integration of glutamatergic and dopaminergic signals in the striatum
Kötter, R. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90037-x · Cited by 186
Amantadine reduces levodopa‐induced dyskinesias in parkinsonian monkeys
Blanchet, P. J., Konitsiotis, S., & Chase, T. N. (1998) · Movement Disorders · doi:10.1002/mds.870130507 · Cited by 185
Effect of Nondopaminergic Drugs on L-DOPA-Induced Dyskinesias in MPTP-Treated Monkeys
Gomez-Mancilla, B., & Bedard, P. J. (1993) · Clinical Neuropharmacology · doi:10.1097/00002826-199310000-00004 · Cited by 181
Lévesque, D., Martres, M. P., Diaz, J., Griffon, N., Lammers, C. H., Sokoloff, P., & Schwartz, J. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1719 · Cited by 180
Piccini, P., Weeks, R. A., & Brooks, D. J. (1997) · Annals of Neurology · doi:10.1002/ana.410420508 · Cited by 177
Dopamine-dependent synaptic plasticity in striatum during in vivo development
Tang, K.-C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031374698 · Cited by 171
Continuous dopamine-receptor stimulation in advanced Parkinson's disease
Nutt, J. G., Obeso, J. A., & Stocchi, F. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00029-x · Cited by 171
Filion, M. (1979) · Brain Research · doi:10.1016/0006-8993(79)90704-2 · Cited by 168
On the Role of Enkephalin Cotransmission in the GABAergic Striatal Efferents to the Globus Pallidus
Maneuf, Y. P., Mitchell, I., Crossman, A. R., & Brotchie, J. M. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1007 · Cited by 164
Self-citationCortical motor overactivation in parkinsonian patients with L-dopa- induced peak-dose dyskinesia
Rascol, O. (1998) · Brain · doi:10.1093/brain/121.3.527 · Cited by 164
Tedroff, J., Pedersen, M., Aquilonius, S.-M., Hartvig, P., Jacobsson, G., & Långström, B. (1996) · Neurology · doi:10.1212/wnl.46.5.1430 · Cited by 161
Henry, B., Crossman, A. R., & Brotchie, J. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6996 · Cited by 158
Self-citationVila, M., Levy, R., Herrero, M.-T., Ruberg, M., Faucheux, B., Obeso, J. A., Agid, Y., & Hirsch, E. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00765.1997 · Cited by 158
Blanchet, P. J., Konitsiotis, S., Whittemore, E. R., Zhou, Z. L., Woodward, R. M., & Chase, T. N. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35003-7 · Cited by 158
Wegner, C., & Nau, H. (1992) · PubMed · Cited by 158
Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease.
Muenter, M. D., Sharpless, N. S., Tyce, G. M., & Darley, F. L. (1977) · PubMed · Cited by 151
Rascol, O., Nutt, J. G., Blin, O. J., Goetz, C. G., Trugman, J. M., Soubrouillard, C., Carter, J. H., Currie, L. J., Fabre, N., Thalamas, C., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.2.249 · Cited by 149
Ingham, C. A., Hood, S. H., van Maldegem, B., Weenink, A., & Arbuthnott, G. W. (1993) · Experimental Brain Research · doi:10.1007/bf00227776 · Cited by 144
Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine.
Lozano, A. M., Lang, A. E., Levy, R., Hutchison, W. D., & Dostrovsky, J. O. (2000) · PubMed · Cited by 142
Fortnightly Review: Drug treatment of Parkinson's disease
Quinn, N. P. (1995) · BMJ · doi:10.1136/bmj.310.6979.575 · Cited by 142
Preventing levodopa-induced dyskinesias.
Olanow, C. W., & Obeso, J. A. (2000) · PubMed · Cited by 140
Herrero, M. T., Augood, S. J., Hirsch, É. C., Javoy-Agid, F., Luquín, M. R., Agid, Y., Obeso, J. A., & Emson, P. C. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00120-8 · Cited by 139
Neostriatal enkephalin-immunoreactive neurones project to the globus pallidus
Fiacco, M. D., Paxinos, G., & Cuello, A. C. (1982) · Brain Research · doi:10.1016/0006-8993(82)90003-8 · Cited by 137
Bordet, R., Ridray, S., Schwartz, J.-C., & Sokoloff, P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00089.x · Cited by 135
Engber, T. M., Susel, Z., Juncos, J. L., & Chase, T. N. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90790-5 · Cited by 133
A 2-DEOXYGLUCOSE STUDY OF THE EFFECTS OF DOPAMINE AGONISTS ON THE PARKINSONIAN PRIMATE BRAIN
Mitchell, I., Boyce, S., Sambrook, M. A., & Crossman, A. R. (1992) · Brain · doi:10.1093/brain/115.3.809 · Cited by 128
Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum
Calabresi, P., Pisani, A., Centonze, D., & Bernardi, G. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00029-2 · Cited by 117
Brotchie, J. M. (1998) · Movement Disorders · doi:10.1002/mds.870130603 · Cited by 111
Self-citationZeng, B. ‐., Pearce, R. K. B., MacKenzie, G. M., & Jenner, P. G. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00988.x · Cited by 107
Early-Morning Dystonia: A Late Side Effect of Long-term Levodopa Therapy in Parkinson's Disease
Melamed, E. (1979) · Archives of Neurology · doi:10.1001/archneur.1979.00500410086014 · Cited by 106
Klawans, H. L., Goetz, C. G., & Bergen, D. C. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490470075011 · Cited by 103
Morissette, M., Grondin, R., Goulet, M., Bédard, P. J., & Paolo, T. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720682.x · Cited by 101
Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions
Menegoz, M., Lau, L., Hervé, D., Huganir, R. L., & Girault, J. (1995) · Neuroreport · doi:10.1097/00001756-199512290-00030 · Cited by 99
Cellular distribution of adenosine A2A receptor mrna in the primate striatum
Svenningsson, P., Moine, C. L., Aubert, I., Burbaud, P., Fredholm, B. B., & Bloch, B. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980921)399:2<229::aid-cne6>3.0.co;2-2 · Cited by 92
Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum
Lopez, A., Muñoz, A., Guerra, M. J., & Labandeira-García, J. L. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00588-1 · Cited by 91
Nash, J. E., & Brotchie, J. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07782.2000 · Cited by 90
Self-citationBrooks, D. J., Piccini, P. P., Turjanski, N., & Samuel, M. (2000) · PubMed · Cited by 87
Steiner, H., & Gerfen, C. R. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961223)376:4<530::aid-cne3>3.0.co;2-2 · Cited by 86
Graham, W. C., Sambrook, M. A., & Crossman, A. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90694-i · Cited by 85
Tobin, G., & Sjögren, C. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00221-6 · Cited by 85
Rascol, O., Fabre, N., Blin, O. J., Poulik, J. M., Sabatini, U., Sénard, J., Ané, M., Montastruc, J., & Rascol, A. (1994) · Movement Disorders · doi:10.1002/mds.870090410 · Cited by 82
Fox, S. H., Henry, B., Hill, M. P., Peggs, D., Crossman, A. R., & Brotchie, J. M. (2001) · Movement Disorders · doi:10.1002/mds.1148 · Cited by 82
Self-citationAromatic L‐amino acid decarboxylase in rat corpus striatum
Melamed, E., Hefti, F. F., Pettibone, D. J., Liebman, J., & Wurtman, R. J. (1981) · Neurology · doi:10.1212/wnl.31.6.651 · Cited by 80
Bézard, E., Crossman, A. R., Gross, C. E., & Brotchie, J. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0637fje · Cited by 77
Self-citation??2-Adrenoceptor Antagonists: A New Approach to Parkinson??s Disease?
Brefel‐Courbon, C., Thalamas, C., Paul, H. P. S., Sénard, J., Montastruc, J., & Rascol, O. (1998) · CNS Drugs · doi:10.2165/00023210-199810030-00004 · Cited by 71
Maneuf, Y. P., Mitchell, I., Crossman, A. R., Woodruff, G. N., & Brotchie, J. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00358-w · Cited by 71
Self-citationDziewczapolski, G., Menalled, L., García, M. C., Mora, M. A., Gershanik, O. S., & Rubinstein, M. (1998) · Neuroreport · doi:10.1097/00001756-199801050-00001 · Cited by 66
Modulation of glutamate release by a κ-opioid receptor agonist in rodent and primate striatum
Hill, M. P., & Brotchie, J. M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00385-x · Cited by 54
Self-citationGross, C. E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00015-5 · Cited by 52
Self-citationPallidotomy for Parkinson’s Disease
Lozano, A. M., & Lang, A. E. (1998) · Neurosurgery Clinics of North America · doi:10.1016/s1042-3680(18)30268-7 · Cited by 52
Effect of an Opiate Antagonist on Movement Disorders
Nutt, J. G., Rosin, A. J., Eisler, T., Calne, D. B., & Chase, T. N. (1978) · Archives of Neurology · doi:10.1001/archneur.1978.00500360034006 · Cited by 48
Jenner, P. G. (2000) · Journal of Neurology · doi:10.1007/pl00007760 · Cited by 47
Stefani, A., Stanzione, P., Bassi, A., Mazzone, P., Vangelista, T., & Bernardi, G. (1997) · Journal of Neural Transmission · doi:10.1007/bf01285557 · Cited by 42
Variations in the "on-off" phenomenon.
Duvoisin, R. C. (1974) · PubMed · Cited by 42
L-Tryptophan in the Treatment of Restless Legs Syndrome
Sandyk, R. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.4.554-b · Cited by 38
Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey
Bézard, E., Brefel‐Courbon, C., Tison, F., Peyro-Saint-Paul, H., Ladure, P., Rascol, O., & Gross, C. E. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00067-6 · Cited by 34
Self-citationGanguly, A., & Keefe, K. A. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00005-7 · Cited by 28
Pharmacokinetics and pharmacodynamics of levodopa.
Eb, M. (1992) · PubMed · Cited by 22
Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Waldvogel (1999) · doi:10.1002/1531-8249(199907)46:1
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“Because both the SNr and GPi provide inhibitory output to motor nuclei outside the basal ganglia (e.g., motor thalamus and brain stem locomotor regions), this mechanism is thought to contribute to the excessive motor inhibition in PD (Obeso et al., 2000; Bezard et al., 2001).”
BackgroundLoss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821
“Despite the clinical importance of this complication, little is known about its cause”
BackgroundDuty, S., & Jenner, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01426.x · Cited by 753
The cerebellum in Parkinson’s disease
Wu, T., & Hallett, M. (2013) · Brain · doi:10.1093/brain/aws360 · Cited by 748
Lundblad, M., Andersson, M., Winkler, C., Kirik, D., Wierup, N., & Cenci, M. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01843.x · Cited by 664
Metadata
- Authors
- Bezard, E., Brotchie, J. M., & Gross, C. E.
- Venue
- Nature Reviews Neuroscience
- Published
- 2001-08
- Volume
- 2
- Issue
- 8
- Pages
- 577-588
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2017424741
- Cited by
- 503
- References
- 119
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.